Jonathan Anomaly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jonathan Anomaly has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Julian Savulescu
National University of Singapore
2 shared publications - Alexander I. Young
UCLA
1 shared publication - Bo Winegard
Marietta, USA
1 shared publication - Christopher Gyngell
Biomedical Ethics Research Group, Murdoch Children’s Research Institute, Melbourne, Australia
1 shared publication David Stern
Herasight Research
1 shared publicationDiana Fleischman
University of New Mexico, Albuquerque, USA
1 shared publication
Latest Publications
- Open Access
Development and validation of polygenic scores for within-family prediction of disease risks
The clinical implementation of polygenic scores (PGSs) for disease risk prediction, particularly in reproductive health applications, requires rigorous validation. Here, we develop seventeen disease PGSs by conducting large-scale GWAS meta-analyses, and we validate our scores in out-of-sample prediction analyses. We achieve state-of-the-art predictive performance, consistently matching or outperforming academic and commercial benchmarks, with liability R 2 reaching up to 0.21 (type 2 diabetes). The performance of a PGS for embryo screening depends on its predictive ability within-family, which can be lower than its prediction ability among unrelated individuals. However, very few disease PGSs have been tested within-family. We perform systematic within-family validation of our disease PGSs, finding no decrease in predictive performance within-family for 16 of 17 scores. PGS performance typically declines with genetic distance from training data, an effect that needs to be accounted for to give properly calibrated predictions across ancestries. We perform extensive calibration of our scores’ performance across different ancestries, finding improved cross-ancestry performance compared to previous approaches, especially in African and East Asian populations. This is likely due to the fact our scores are constructed using a method that incorporates functional genomic annotations on more than 7 million variants, enabling a degree of fine-mapping of causal variants shared across ancestries. We illustrate clinical utility through examining the risk reduction that could be achieved through embryo screening for type 2 diabetes: selecting among 10 embryos is expected to reduce absolute disease risk by 12-20% in families where both parents are affected, with similar relative risk reductions across ancestries. These findings establish a framework for implementing PGS in reproductive medicine while demonstrating both the technology’s potential for disease prevention and the methodological standards required for responsible clinical translation.
Open AccessDevelopment and validation of polygenic scores for within-family prediction of disease risks
The clinical implementation of polygenic scores (PGSs) for disease risk prediction, particularly in reproductive health applications, requires rigorous validation. Here, we develop seventeen disease PGSs by conducting large-scale GWAS meta-analyses, and we validate our scores in out-of-sample prediction analyses. We achieve state-of-the-art predictive performance, consistently matching or outperforming academic and commercial benchmarks, with liability R 2 reaching up to 0.21 (type 2 diabetes). The performance of a PGS for embryo screening depends on its predictive ability within-family, which can be lower than its prediction ability among unrelated individuals. However, very few disease PGSs have been tested within-family. We perform systematic within-family validation of our disease PGSs, finding no decrease in predictive performance within-family for 16 of 17 scores. PGS performance typically declines with genetic distance from training data, an effect that needs to be accounted for to give properly calibrated predictions across ancestries. We perform extensive calibration of our scores’ performance across different ancestries, finding improved cross-ancestry performance compared to previous approaches, especially in African and East Asian populations. This is likely due to the fact our scores are constructed using a method that incorporates functional genomic annotations on more than 7 million variants, enabling a degree of fine-mapping of causal variants shared across ancestries. We illustrate clinical utility through examining the risk reduction that could be achieved through embryo screening for type 2 diabetes: selecting among 10 embryos is expected to reduce absolute disease risk by 12-20% in families where both parents are affected, with similar relative risk reductions across ancestries. These findings establish a framework for implementing PGS in reproductive medicine while demonstrating both the technology’s potential for disease prevention and the methodological standards required for responsible clinical translation.
- Open Access
- 1 September 2023
- Published by Springer Nature in Journal of Bioethical Inquiry
- Vol. 21 (1) , 167-175
Flesh Without Blood: The Public Health Benefits of Lab‐Grown Meat
Synthetic meat made from animal cells will transform how we eat. It will reduce suffering by eliminating the need to raise and slaughter animals. But it will also have big public health benefits if it becomes widely consumed. In this paper, we discuss how “clean meat” can reduce the risks associated with intensive animal farming, including antibiotic resistance, environmental pollution, and zoonotic viral diseases like influenza and coronavirus. Since the most common objection to clean meat is that some people find it “disgusting” or “unnatural,” we explore the psychology of disgust to find possible counter-measures. We argue that the public health benefits of clean meat give us strong moral reasons to promote its development and consumption in a way that the public is likely to support. We end by depicting the change from farmed animals to clean meat as a collective action problem and suggest that social norms rather than coercive laws should be employed to solve the problem.
- 1 September 2023
- Published by Springer Nature in Journal of Bioethical Inquiry
- Vol. 21 (1) , 167-175
Open AccessFlesh Without Blood: The Public Health Benefits of Lab‐Grown Meat
Synthetic meat made from animal cells will transform how we eat. It will reduce suffering by eliminating the need to raise and slaughter animals. But it will also have big public health benefits if it becomes widely consumed. In this paper, we discuss how “clean meat” can reduce the risks associated with intensive animal farming, including antibiotic resistance, environmental pollution, and zoonotic viral diseases like influenza and coronavirus. Since the most common objection to clean meat is that some people find it “disgusting” or “unnatural,” we explore the psychology of disgust to find possible counter-measures. We argue that the public health benefits of clean meat give us strong moral reasons to promote its development and consumption in a way that the public is likely to support. We end by depicting the change from farmed animals to clean meat as a collective action problem and suggest that social norms rather than coercive laws should be employed to solve the problem.
- Top Cited PapersOpen Access
- 8 July 2022
- Published by Springer Nature
- p. 153-171
Race, Eugenics, and the Holocaust
This chapter will focus on how the Holocaust shaped the concepts of race and eugenics in bioethics. I will begin with a brief account of how these terms were used before the Second World War, and then discuss how the Nazi eugenics programs and the Holocaust altered how scholars think about race and eugenics. In particular, I will discuss the 1948 United Nations Declaration of Human Rights and 1950 Statement on Race, which signaled a change in how race and eugenics would be used in the second half of the twentieth century. Finally, I will consider how liberal eugenics in contemporary bioethics differs from older forms of eugenics, and how newer views about human populations (as genetic clusters) differ from older views of race. In doing so, I will explore how the Holocaust shaped modern taboos related to human genetics research.
- 8 July 2022
- Published by Springer Nature
- p. 153-171
Top Cited PapersOpen AccessRace, Eugenics, and the Holocaust
This chapter will focus on how the Holocaust shaped the concepts of race and eugenics in bioethics. I will begin with a brief account of how these terms were used before the Second World War, and then discuss how the Nazi eugenics programs and the Holocaust altered how scholars think about race and eugenics. In particular, I will discuss the 1948 United Nations Declaration of Human Rights and 1950 Statement on Race, which signaled a change in how race and eugenics would be used in the second half of the twentieth century. Finally, I will consider how liberal eugenics in contemporary bioethics differs from older forms of eugenics, and how newer views about human populations (as genetic clusters) differ from older views of race. In doing so, I will explore how the Holocaust shaped modern taboos related to human genetics research.
- Open Access
- 3 June 2021
- Published by Springer Nature in Public Choice
- Vol. 195 (1-2) , 1-11
What is public health? public goods, publicized goods, and the conversion problem
Public health programs began as an attempt to fight infectious diseases that are difficult to address without collective action. But the concept and practice of public health has ballooned to encompass an expanding list of controversial public policy goals ranging from reducing obesity to raising self-esteem. As the list of controversial goals expands, support for “public health” measures contracts. I’ll briefly defend the view that we should define public health as the provision of health-related public goods. I’ll then show that being a health-related public good is not a sufficient condition for counting as a public health goal, since virtually any private good can be converted into a public good by government fiat. This is the conversion problem, which challenges the way we ordinarily think about public goods and public health.
- 3 June 2021
- Published by Springer Nature in Public Choice
- Vol. 195 (1-2) , 1-11
Open AccessWhat is public health? public goods, publicized goods, and the conversion problem
Public health programs began as an attempt to fight infectious diseases that are difficult to address without collective action. But the concept and practice of public health has ballooned to encompass an expanding list of controversial public policy goals ranging from reducing obesity to raising self-esteem. As the list of controversial goals expands, support for “public health” measures contracts. I’ll briefly defend the view that we should define public health as the provision of health-related public goods. I’ll then show that being a health-related public good is not a sufficient condition for counting as a public health goal, since virtually any private good can be converted into a public good by government fiat. This is the conversion problem, which challenges the way we ordinarily think about public goods and public health.
- Open Access
- 27 October 2020
- Published by Springer Nature
- p. 297-308
Antibiotics and Animal Agriculture: The Need for Global Collective Action
The use of antibiotics in animal agriculture is steadily increasing, especially in developing countries. The European Union and a handful of developed countries have implemented policies to scale back the use of antibiotics, recognizing its role in the global rise of antibiotic resistance. But many farmers who raise animals live in poor countries without public health regulations, or work for large corporate entities that can move their operations to places with weak regulations. To minimize the careless use of antibiotics around the world, we need multi-lateral coordination between states on some common standards for the use of antibiotics in animals.
- 27 October 2020
- Published by Springer Nature
- p. 297-308
Open AccessAntibiotics and Animal Agriculture: The Need for Global Collective Action
The use of antibiotics in animal agriculture is steadily increasing, especially in developing countries. The European Union and a handful of developed countries have implemented policies to scale back the use of antibiotics, recognizing its role in the global rise of antibiotic resistance. But many farmers who raise animals live in poor countries without public health regulations, or work for large corporate entities that can move their operations to places with weak regulations. To minimize the careless use of antibiotics around the world, we need multi-lateral coordination between states on some common standards for the use of antibiotics in animals.
- Open Access
- 22 February 2020
- Published by Springer Nature in Philosophia
- Vol. 48 (5) , 1753-1768
Cognitive Enhancement and Network Effects: how Individual Prosperity Depends on Group Traits
A central debate in bioethics is whether parents should try to influence the genetic basis of their children’s traits. We argue that the case for using mate selection, embryo selection, and other interventions to enhance heritable traits like intelligence is strengthened by the fact that they seem to have positive network effects. These network effects include increased cooperation in collective action problems, which contributes to social trust and prosperity. We begin with an overview of evidence for these claims, and then argue that if individual welfare is largely a function of group traits, parents should try to preserve or enhance cognitive traits that have positive network effects.
- 22 February 2020
- Published by Springer Nature in Philosophia
- Vol. 48 (5) , 1753-1768
Open AccessCognitive Enhancement and Network Effects: how Individual Prosperity Depends on Group Traits
A central debate in bioethics is whether parents should try to influence the genetic basis of their children’s traits. We argue that the case for using mate selection, embryo selection, and other interventions to enhance heritable traits like intelligence is strengthened by the fact that they seem to have positive network effects. These network effects include increased cooperation in collective action problems, which contributes to social trust and prosperity. We begin with an overview of evidence for these claims, and then argue that if individual welfare is largely a function of group traits, parents should try to preserve or enhance cognitive traits that have positive network effects.
- Open Access
- 20 February 2020
- Published by Oxford University Press (OUP) in Public Health Ethics
- Vol. 13 (1) , 82-88
The Future of Phage: Ethical Challenges of Using Phage Therapy to Treat Bacterial Infections
For over a century, scientists have run experiments using phage viruses to treat bacterial infections. Until recently, the results were inconclusive because the mechanisms viruses use to attack bacteria were poorly understood. With the development of molecular biology, scientists now have a better sense of how phage work, and how they can be used to target infections. As resistance to traditional antibiotics continues to spread around the world, there is a moral imperative to facilitate research into phage therapy as an alternative treatment. This essay reviews ethical questions raised by phage therapy, and discusses regulatory challenges associated with phage research, and phage treatments.
- 20 February 2020
- Published by Oxford University Press (OUP) in Public Health Ethics
- Vol. 13 (1) , 82-88
Open AccessThe Future of Phage: Ethical Challenges of Using Phage Therapy to Treat Bacterial Infections
For over a century, scientists have run experiments using phage viruses to treat bacterial infections. Until recently, the results were inconclusive because the mechanisms viruses use to attack bacteria were poorly understood. With the development of molecular biology, scientists now have a better sense of how phage work, and how they can be used to target infections. As resistance to traditional antibiotics continues to spread around the world, there is a moral imperative to facilitate research into phage therapy as an alternative treatment. This essay reviews ethical questions raised by phage therapy, and discusses regulatory challenges associated with phage research, and phage treatments.
- 28 January 2020
- Published by Taylor & Francis
Creating Future People
Creating Future People offers readers a fast-paced primer on how new genetic technologies will enable parents to influence the traits of their children, including their intelligence, moral capacities, physical appearance, and immune system. It deftly explains the science of gene editing and embryo selection, and raises the central moral questions with colorful language and a brisk style. Jonathan Anomaly takes seriously the diversity of preferences parents have, and the limits of public policy in regulating what could soon be a global market for reproductive technology. He argues that once embryo selection for complex traits happens it will change the moral landscape by altering the incentives parents face. All of us will take an interest in the traits everyone else selects, and this will present coordination problems that previous writers on genetic enhancement have failed to consider. Anomaly navigates difficult ethical issues with vivid language and scientifically informed speculation about how genetic engineering will transform humanity. Key features: Offers clear explanations of scientific concepts; Explores important moral questions without academic jargon; Brings discoveries from different fields together to give us a sense of where humanity is headed.
- 28 January 2020
- Published by Taylor & Francis
Creating Future People
Creating Future People offers readers a fast-paced primer on how new genetic technologies will enable parents to influence the traits of their children, including their intelligence, moral capacities, physical appearance, and immune system. It deftly explains the science of gene editing and embryo selection, and raises the central moral questions with colorful language and a brisk style. Jonathan Anomaly takes seriously the diversity of preferences parents have, and the limits of public policy in regulating what could soon be a global market for reproductive technology. He argues that once embryo selection for complex traits happens it will change the moral landscape by altering the incentives parents face. All of us will take an interest in the traits everyone else selects, and this will present coordination problems that previous writers on genetic enhancement have failed to consider. Anomaly navigates difficult ethical issues with vivid language and scientifically informed speculation about how genetic engineering will transform humanity. Key features: Offers clear explanations of scientific concepts; Explores important moral questions without academic jargon; Brings discoveries from different fields together to give us a sense of where humanity is headed.
- 1 January 2020
- Published by WellBeing International Publications in Animal Sentience
- Vol. 5 (30) , 5
Cultured meat could prevent the next pandemic
Wiebers & Feigin identify intensive agriculture and trade in exotic animals as the main sources of novel zoonotic viral infections. They recommend a transition away from meat. I would add that we would do well to invest in the mass production of cultured meat, derived from stem cells, as a radical alternative to animal agriculture.
- 1 January 2020
- Published by WellBeing International Publications in Animal Sentience
- Vol. 5 (30) , 5
Cultured meat could prevent the next pandemic
Wiebers & Feigin identify intensive agriculture and trade in exotic animals as the main sources of novel zoonotic viral infections. They recommend a transition away from meat. I would add that we would do well to invest in the mass production of cultured meat, derived from stem cells, as a radical alternative to animal agriculture.